Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,636 | 298,395 | 171,445 | 130,237 | 89,512 |
| Marketable Securities | N/A | N/A | 19,821 | 10,041 | 5,007 |
| Receivables | 53,514 | 10,439 | 6,619 | 5,987 | 10,537 |
| Inventories | 15,644 | 6,805 | 7,870 | 4,651 | 1,957 |
| TOTAL | $219,329 | $320,806 | $210,106 | $159,244 | $111,364 |
| Non-Current Assets | |||||
| PPE Net | 1,195 | 847 | 959 | 130 | 211 |
| Investments And Advances | 16,489 | 0 | 0 | 0 | 0 |
| Intangibles | 194,049 | 32,471 | 0 | 0 | 0 |
| Other Non-Current Assets | 39,052 | 21,506 | 26,723 | 32,980 | 802 |
| TOTAL | $250,785 | $54,824 | $27,682 | $33,110 | $1,013 |
| Total Assets | $470,114 | $375,630 | $237,788 | $192,354 | $112,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,795 | 3,975 | 2,768 | 4,256 | 4,117 |
| Accrued Expenses | 61,268 | 53,613 | 24,295 | 18,500 | 19,981 |
| TOTAL | $76,063 | $57,588 | $27,063 | $22,756 | $24,099 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,170 | 17,621 | 3,894 | 0 | 648 |
| TOTAL | $6,170 | $17,621 | $3,894 | $N/A | $648 |
| Total Liabilities | $82,233 | $75,209 | $30,957 | $22,756 | $24,746 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,863 | 105,654 | 102,745 | 103,825 | 103,409 |
| Common Shares | 107 | 105 | 103 | 104 | 103 |
| Retained earnings | 121,272 | 49,862 | -26,310 | -53,705 | -128,689 |
| Other shareholders' equity | 14 | 24 | -148 | 31 | 10 |
| TOTAL | $387,881 | $300,421 | $206,831 | $169,598 | $87,630 |
| Total Liabilities And Equity | $470,114 | $375,630 | $237,788 | $192,354 | $112,376 |